Signaturefd, LLC Cerus Corp Transaction History

Signaturefd, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$2.65 - $3.81 $946 - $1,360	357 Added 129.82%	632 $1,000
Q4 2022 Jan 27, 2023	BUY	$3.38 - $4.22 $392 - $489	116 Added 72.96%	275 $1,000
Q3 2022 Nov 08, 2022	BUY	$3.43 - $5.83 $545 - $926	159 New	159 $1,000
Q1 2022 May 02, 2022	SELL	$4.81 - $6.99 $2,405 - $3,495	-500 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$5.97 - $7.93 $2,985 - $3,965	500 New	500 $3,000
Q3 2021 Oct 28, 2021	SELL	$4.79 - $6.68 $383 - $534	-80 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$5.35 - $6.35 $428 - $508	80 New	80 $0
Q4 2020 Feb 11, 2021	SELL	$5.25 - $8.56 $1,517 - $2,473	-289 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$5.78 - $7.47 $132 - $171	23 Added 8.65%	289 $2,000
Q2 2020 Jul 30, 2020	BUY	$4.5 - $7.02 $1,197 - $1,867	266 New	266 $2,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.